Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-11 Sale |
2025-02-12 1:59 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
363 | $28.54 | $10,360 | 83,945 (Direct) |
View |
| 2025-01-29 Sale |
2025-01-30 12:01 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
365 | $29.52 | $10,776 | 84,308 (Direct) |
View |
| 2025-01-22 Sale |
2025-01-23 3:23 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
1,396 | $30.43 | $42,474 | 84,673 (Direct) |
View |
| 2025-01-17 Sale |
2025-01-21 3:59 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
1,235 | $29.96 | $36,998 | 86,069 (Direct) |
View |
| 2025-01-13 Sale |
2025-01-14 4:10 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
1,599 | $28.7 | $45,895 | 58,796 (Direct) |
View |
| 2024-03-18 Sale |
2024-03-19 4:03 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
9,913 | $56.9 | $564,050 | 54,693 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 4:38 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
597 | $67.77 | $40,457 | 64,606 (Direct) |
View |
| 2024-01-29 Sale |
2024-01-31 4:18 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
367 | $64.14 | $23,539 | 65,203 (Direct) |
View |
| 2024-01-22 Sale |
2024-01-23 6:01 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
1,384 | $65 | $89,954 | 65,570 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 4:41 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
1,631 | $66.81 | $108,965 | 91,620 (Direct) |
View |
| 2023-10-23 Sale |
2023-10-24 4:18 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
131 | $46.04 | $6,031 | 51,622 (Direct) |
View |
| 2022-08-17 Sale |
2022-08-18 4:02 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $69.5 | $347,500 | 29,250 (Direct) |
View |
| 2022-08-11 Sale |
2022-08-12 4:58 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $67 | $335,000 | 34,250 (Direct) |
View |
| 2022-08-08 Sale |
2022-08-09 5:16 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $64.5 | $322,500 | 39,250 (Direct) |
View |
| 2022-08-04 Sale |
2022-08-08 4:02 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
10,000 | $60.75 | $607,500 | 44,250 (Direct) |
View |
| 2022-07-27 Sale |
2022-07-28 4:03 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $57 | $285,000 | 54,250 (Direct) |
View |
| 2022-07-19 Sale |
2022-07-21 4:31 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $56.42 | $282,100 | 59,250 (Direct) |
View |
| 2022-06-16 Sale |
2022-06-21 4:11 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
10,000 | $41.78 | $417,850 | 49,250 (Direct) |
View |
| 2022-04-20 Sale |
2022-04-22 5:35 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
7,000 | $52.53 | $367,710 | 63,481 (Direct) |
View |
| 2021-07-21 Sale |
2021-07-22 4:24 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
1,000 | $65 | $65,000 | 51,490 (Direct) |
View |
| 2021-07-15 Sale |
2021-07-16 6:40 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
1,000 | $62.3 | $62,300 | 52,490 (Direct) |
View |
| 2021-06-15 Sale |
2021-06-16 4:32 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
4,000 | $64.96 | $259,830 | 53,490 (Direct) |
View |
| 2021-05-18 Sale |
2021-05-19 4:04 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
2,000 | $55 | $110,000 | 57,490 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-21 Option Award |
2025-01-21 3:59 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
28,508 | $0 | 86,069 (Direct) |
View |
| 2024-08-12 Exercise |
2024-08-13 4:13 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
5,201 | $13.85 | 75,194 (Direct) |
View |
| 2024-08-12 Exercise |
2024-08-13 4:13 pm |
N/A 2029-02-27 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
5,201 | $0 | 75,194 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:41 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
24,666 | $66.3 | 91,620 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:41 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
16,963 | $0 | 91,620 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-22 06:46 am |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
12,769 | $0 | 58,830 (Direct) |
View |
| 2023-02-21 Tax Withholding |
2023-02-22 06:46 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
441 | $58.5 | 58,830 (Direct) |
View |
| 2023-02-10 Tax Withholding |
2023-02-14 4:24 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
670 | $51.21 | 46,502 (Direct) |
View |
| 2023-01-27 Tax Withholding |
2023-01-30 4:45 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
367 | $52.77 | 47,172 (Direct) |
View |
| 2023-01-20 Tax Withholding |
2023-01-24 5:12 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
1,149 | $52.05 | 47,539 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-17 7:28 pm |
N/A 2033-01-11 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
30,845 | $52.66 | 79,533 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-17 7:28 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
19,634 | $0 | 79,533 (Direct) |
View |
| 2022-10-20 Tax Withholding |
2022-10-24 5:10 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
196 | $58 | 29,054 (Direct) |
View |
| 2022-08-17 Exercise |
2022-08-18 4:02 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $15.52 | 29,250 (Direct) |
View |
| 2022-08-17 Exercise |
2022-08-18 4:02 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $0 | 29,250 (Direct) |
View |
| 2022-08-11 Exercise |
2022-08-12 4:58 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $15.52 | 34,250 (Direct) |
View |
| 2022-08-11 Exercise |
2022-08-12 4:58 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $0 | 34,250 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-09 5:16 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $15.52 | 39,250 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-09 5:16 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $0 | 39,250 (Direct) |
View |
| 2022-08-04 Exercise |
2022-08-08 4:02 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
10,000 | $15.52 | 44,250 (Direct) |
View |
| 2022-08-04 Exercise |
2022-08-08 4:02 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
10,000 | $0 | 44,250 (Direct) |
View |
| 2022-07-27 Exercise |
2022-07-28 4:03 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $15.52 | 54,250 (Direct) |
View |
| 2022-07-27 Exercise |
2022-07-28 4:03 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $0 | 54,250 (Direct) |
View |
| 2022-07-19 Exercise |
2022-07-21 4:31 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $15.52 | 59,250 (Direct) |
View |
| 2022-07-19 Exercise |
2022-07-21 4:31 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $0 | 59,250 (Direct) |
View |
| 2022-06-16 Exercise |
2022-06-21 4:11 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
10,000 | $13.85 | 49,250 (Direct) |
View |
| 2022-06-16 Exercise |
2022-06-21 4:11 pm |
N/A 2029-02-27 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
10,000 | $0 | 49,250 (Direct) |
View |
| 2022-04-20 Exercise |
2022-04-22 5:35 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
7,000 | $15.52 | 63,481 (Direct) |
View |
| 2022-04-20 Exercise |
2022-04-22 5:35 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
7,000 | $0 | 63,481 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:13 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
271 | $47.12 | 35,433 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 4:13 pm |
N/A 2032-02-09 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
11,853 | $0 | 35,433 (Direct) |
View |
| 2022-01-21 Option Award(A) |
2022-02-07 8:06 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
33,648 | $0 | 44,020 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:10 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
434 | $38.59 | 20,530 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 4:37 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
25,616 | $0 | 35,988 (Direct) |
View |
| 2021-10-20 Option Award |
2021-10-27 4:26 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
882 | $0 | 10,372 (Direct) |
View |
| 2021-07-21 Exercise |
2021-07-22 4:24 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
1,000 | $15.52 | 51,490 (Direct) |
View |
| 2021-07-21 Exercise |
2021-07-22 4:24 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
1,000 | $0 | 51,490 (Direct) |
View |
| 2021-07-15 Exercise |
2021-07-16 6:40 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
1,000 | $15.52 | 52,490 (Direct) |
View |
| 2021-07-15 Exercise |
2021-07-16 6:40 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
1,000 | $0 | 52,490 (Direct) |
View |
| 2021-06-15 Exercise |
2021-06-16 4:32 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
4,000 | $15.52 | 53,490 (Direct) |
View |
| 2021-06-15 Exercise |
2021-06-16 4:32 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
4,000 | $0 | 53,490 (Direct) |
View |
| 2021-05-18 Exercise |
2021-05-19 4:04 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
2,000 | $15.52 | 57,490 (Direct) |
View |
| 2021-05-18 Exercise |
2021-05-19 4:04 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
2,000 | $0 | 57,490 (Direct) |
View |
Ownership |
2021-04-09 4:04 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
0 | $0 | 137,448 (Direct) |
View |